Marie-Claude Morice

Showing 1-20 of 57 articles

Author Massimo Mancone

Coronary interventions

Major Infections after Bypass Surgery and Stenting for Multivessel Coronary Disease: An analysis of the randomized SYNTAX trial

Mancone M, Cavalcante R, Modolo R, Falcone M, Biondi-Zoccai G, Frati G, Spitzer E, Benedetto U, Blackstone E, Onuma Y, van Geuns R, Diletti R, Serruys P, Morice M-C, Holmes D, Lemos P, Sardella G, Fedele F, Morel M-A, Collet C, Steyerberg E

July 9, 2019 | 10.4244/EIJ-D-19-00208

Author Shmuel Chen

Does an Occluded RCA Affect Prognosis in Patients Undergoing PCI or CABG for Left Main Coronary Artery Disease? Analysis From the EXCEL Trial

Chen S, Karmpaliotis D, Redfors B, Shlofmitz E, Ben-Yehuda O, Crowley A, Mehdipoor G, Puskas JD, Kandzari D, Banning A, Morice M-C, Taggart D, Sabik III JF, Serruys P, Kappetein A, Stone G.W.

June 11, 2019 | 10.4244/EIJ-D-19-00263

Author Alaide Chieffo

Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee

Chieffo A, Buchanan G, Mehilli J, Capodanno D, Kunadian V, Petronio AS, Mikhail G, Capranzano P, Gonzalo N, Karam N, Manzo-Silberman S, Schüpke S, Byrne R, Capretti G, Appelman Y, Morice M-C, Presbitero P, Radu M, Mauri J

December 7, 2018 | 10.4244/EIJ-D-18-00225

Author Shmuel Chen

Coronary interventions

Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial

Chen S, Redfors B, Liu Y, Ben-Yehuda O, Morice M-C, Leon M, Kandzari D, Mehran R, Lembo N, Banning A, Merkely B, Kappetein AP, Sabik rd J, Serruys P, Stone G.W.

November 20, 2018 | 10.4244/EIJ-D-18-00711

Author Janusz Lipiecki

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial

Lipiecki J, Brunel P, Morice M-C, Roguelov C, Walsh S, Richardt G, Eerdmans P, Zambahari R, Berland J, Copt S, Stoll H-P, Urban P

July 20, 2018 | 10.4244/EIJ-D-18-00293

Author Simon J. Walsh

Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study

Walsh S, Hanratty C, Watkins S, Oldroyd K, Mulvihill N, Hensey M, Chase A, Smith D, Cruden N, Spratt J, Mylotte D, Johnson T, Hill J, Hussein H, Bogaerts K, Morice M-C, Foley DP

June 14, 2018 | 10.4244/EIJ-D-18-00346

Author Milan Milojevic

Stable CAD

The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial

Milojevic M, Head S, Mack M, Mohr F, Morice M-C, Dawkins K, Holmes D, Serruys P, Kappetein AP

May 20, 2018 | 10.4244/EIJ-D-17-00620

Author Christoph J. Jensen

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

Jensen C, Naber C, Urban P, Ong PJ, Valdés Chávarri M, Abizaid A, Pocock S, Fabbiocchi F, Dubois C, Copt S, Stoll H-P, Morice M-C

March 20, 2018 | 10.4244/EIJ-D-17-00720

Author Antoine Filipovic-Pierucci

Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial

Filipovic-Pierucci A, Durand-Zaleski I, Butel T, Greene S, Hovasse T, Iniguez A, Nazzaro M, Oldroyd K, Talwar S, Richardt G, Windhovel U, Urban P, Morice M-C

February 20, 2018 | 10.4244/EIJ-D-17-00286

Author Andrew K. Roy

Coronary interventions

Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?

Roy A, Chevalier B, Lefèvre T, Louvard Y, Segurado R, Sawaya F, Spaziano M, Neylon A, Serruys P, Dawkins K, Kappetein AP, Mohr F, Colombo A, Feldman T, Morice M-C

September 20, 2017 | 10.4244/EIJ-D-16-00991

Author Francesca Sanguineti

Coronary interventions

Chronic total coronary occlusion treated by percutaneous coronary intervention: long-term outcome in patients with and without diabetes

Sanguineti F, Garot P, O’Connor S, Watanabe Y, Spaziano M, Lefèvre T, Hovasse T, Benamer H, Unterseeh T, Chevalier B, Morice M-C, Louvard Y

February 3, 2017 | 10.4244/EIJ-D-15-00278

Author Olivier Varenne

Coronary interventions

The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study

Varenne O, Cuisset T, Chaib A, Morice M-C, Sabaté M, Koh T-H, Durand-Zaleski I, Hanon O, Bogaerts K, Sinnaeve P

January 20, 2017 | 10.4244/EIJY15M12_02

Author Arie-Pieter Kappetein

Coronary interventions

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

Kappetein AP, Serruys P, Sabik J, Leon M, Taggart D, Morice M-C, Gersh B, Pocock S, Cohen D, Wallentin L, Ben-Yehuda O, Van Es G-A, Simonton C, Stone G.W.

September 18, 2016 | 10.4244/EIJV12I7A141

Author Stylianos A. Pyxaras

Coronary interventions

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment

Pyxaras S, Hunziker L, Chieffo A, Meliga E, Latib A, Park S-J, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar R, Palacios I, Kim Y, Buszman P, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon M, Moses J, Fajadet J, Lefèvre T, Morice M-C, Erglis A, Tamburino C, Alfieri O, Serruys P, Colombo A, Naber C

August 5, 2016 | 10.4244/EIJV12I5A102

Author William Wijns

Coronary interventions

Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials

Wijns W, Suttorp MJ, Zagozdzon L, Morice M-C, McClean D, Stella P, Donohoe D, Knape C, Ormiston J

June 20, 2016 | 10.4244/EIJY15M09_14

Author Piera Capranzano

Coronary interventions

Motivations for and barriers to choosing an interventional cardiology career path: results from the EAPCI Women Committee worldwide survey

Capranzano P, Kunadian V, Mauri J, Petronio AS, Salvatella N, Appelman Y, Gilard M, Mikhail G, Schüpke S, Radu M, Vaquerizo B, Presbitero P, Morice M-C, Mehilli J

May 16, 2016 | 10.4244/EIJY15M07_03

Author Andrejs Erglis

Interventions for valvular disease

The Arto transcatheter mitral valve repair system

Erglis A, Thomas M, Morice M-C, Narbute I, Zabunova M, Hovasse T, Poupineau M, Rudzitis A, Kamzola G, Zvaigzne L, Greene S, Rogers J

September 17, 2015 | 10.4244/EIJV11SWA12

Author Stuart Watkins

Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX study

Watkins S, Oldroyd K, Preda I, Holmes D, Colombo A, Morice M-C, Leadley K, Dawkins K, Mohr F, Serruys P, Feldman T

April 20, 2015 | 10.4244/EIJV10I12A244

Author Akiko Maehara

Serial intravascular ultrasound observations from the Tryton first-in-man study

Maehara A, van Geuns R, Louvard Y, M R, Grube E, Morice M-C, Davis H, Kaplan A, Onuma Y, Serruys P, Mintz G

August 19, 2014 | 10.4244/EIJV10I4A81

Author Davide Capodanno

Unmet needs of young interventional cardiologists: proceedings from the 2nd Summit of the European Association of Percutaneous Cardiovascular Interventions

Capodanno D, Ducrocq G, Toth G, Doerler J, Iversen A, Dobric M, Schurtz G, Morice M-C, Windecker S, Gonçalves L, Gilard M, Naber C, Fajadet J

May 20, 2014 | 10.4244/EIJV10I1A9

1
2
3

Latest news

Percutaneous recanalisation of CTO, FAST-TAVI trial, substudy from DANAMI-3-PRIMULTI... discover the latest issue

Computation of OFR by OCT on a LAD with physiologically non-significant stenosis.

Guidance papers

Clinical use of intracoronary imaging Part 2

Read this consensus to appraise ACS, ambiguous coronary angio findings and interventional decision-making

Read the JAA of the week on the Angiolite stent

The new Impact Factor is out!

EuroIntervention IF is 4.018

Special subscription offer!

Register before the end of August and save up to 40% on the regular rates

Guidance papers

Guidelines, consensus & position papers

Late breaking trials

Access the Late Breaking Trials published at EuroPCR 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke